Drug Safety Information for MONISTAT-3 COMBINATION PACK (Miconazole nitrate)

Safety-related Labeling Changes for VUSION (MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE) Rx Drug: FDA Link

Safety-related Labeling Changes for MONISTAT 1 COMBINATION PACK (MICONAZOLE NITRATE) Over-the-counter Drug: FDA Link

if you do not get complete relief ask a doctor before using another product Label update

Adverse Drug Reactions for MONISTAT-3 COMBINATION PACK* (Miconazole nitrate)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with MONISTAT-3 COMBINATION PACK
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Drug interaction227
2International normalised ratio increased159
3Vulvovaginal burning sensation140
4Drug ineffective133
5Vulvovaginal swelling95
6Dyspnoea70
7Diarrhoea63
8Pruritus*56
9Abdominal pain55
10Rash54
11Vulval oedema53
12Pain*53
13Vomiting53
14Pyrexia53
15Nausea53
16Off label use49
17Vulvovaginal pain46
18Hypersensitivity46
19Vulvovaginal pruritus44
20Anaemia44

* This side effect also appears in "Top 10 Side Effects of MONISTAT-3 COMBINATION PACK " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking MONISTAT-3 COMBINATION PACK
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Product used for unknown indication1032
2Fungal infection*704
3Vulvovaginal mycotic infection*612
4Oral candidiasis430
5Tinea pedis112
6Prophylaxis90
7Pruritus81
8Rash80
9Oesophageal candidiasis64
10Antifungal prophylaxis64

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for MONISTAT-3 COMBINATION PACK

Total Reports Filed with FDA: 7682


Number of FDA Adverse Event Reports by Patient Age for MONISTAT-3 COMBINATION PACK

Total Reports Filed with FDA: 7682*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Miconazole nitrate (Desenex, M-zole 7 dual pack, Monistat 5, Miconazole 3, 7 day vaginal, Athletes foot spray, Baza antifungal, Bf-micozo, Critic aid clear af, Dg health miconazole, Elta trivase, Equate athletes foot, Femmesil, Femmesil creme, Hongo killer, Kendall antifungal, Remedy antifungal, Secura antifungal, Soothe and cool free, Sunmark miconazole 7, Terapie anti-fungal, Topcare miconazole 7, Athletes foot, Conazol, Leader medicated, Nail md, Clearly confident, Macerrx web, Miconole, Selan antifungal, Triple paste-af, Micro-guard, Lagicam, Miconazol, Lotrimin af, Mitrazol, Miconazole, Zeasorb, Azolen, Monistat-derm, Tineacide, Micatin, Fungoid tincture, Ting, Miconazole 7, Monistat 7, Monistat 3, Miconazole nitrate)

Charts are based on 7682 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and MONISTAT-3 COMBINATION PACK Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.